Valuation: BOIRON

Market Cap 323M 362M 299M 272M 512M 34.33B 520M 3.6B 1.41B 17.92B 1.36B 1.33B 57.2B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 275M 309M 254M 232M 436M 29.24B 443M 3.07B 1.2B 15.27B 1.16B 1.13B 48.73B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day+3.91%
1 week+5.68%
Current month-7.00%
1 month-26.19%
3 months-30.60%
6 months-26.19%
Current year-38.61%
1 week 16.9
Extreme 16.9
19.5
1 month 16.9
Extreme 16.9
21.5
Current year 16.9
Extreme 16.9
30.95
1 year 16.9
Extreme 16.9
32.25
3 years 16.9
Extreme 16.9
43.96
5 years 16.9
Extreme 16.9
56.5
10 years 16.9
Extreme 16.9
92.7
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
10/29/23 Sell

Director

198,664 1.1323%
10/29/23 Sell

Director

462,964 2.6387%
10/29/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
+3.91%+5.68%-32.36%-64.57% 363M
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average +0.23%+3.82%+27.73%+48.67% 394.13B
Weighted average by Cap. +0.13%+3.83%+39.33%+71.81%

Financials

2024 2025
Net sales 488M 547M 451M 410M 772M 51.83B 785M 5.43B 2.13B 27.06B 2.05B 2B 86.36B 501M 562M 463M 422M 794M 53.27B 807M 5.58B 2.19B 27.81B 2.11B 2.06B 88.76B
Net income 11.34M 12.72M 10.48M 9.54M 17.96M 1.21B 18.26M 126M 49.49M 629M 47.62M 46.61M 2.01B 32.64M 36.62M 30.18M 27.47M 51.72M 3.47B 52.58M 364M 143M 1.81B 137M 134M 5.78B
Net Debt -49.74M -55.8M -45.99M -41.86M -78.8M -5.29B -80.12M -554M -217M -2.76B -209M -204M -8.81B -47.86M -53.69M -44.25M -40.28M -75.82M -5.09B -77.09M -533M -209M -2.66B -201M -197M -8.48B
Projected Income Statement - Annual - BOIRON
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change Volume
26-10-16 €18.60 +3.91% 9,099
26-10-15 €17.90 -0.56% 5,955
26-10-14 €18.00 +6.51% 4,223
26-10-13 €16.90 -2.03% 13,940
26-10-12 €17.25 -1.99% 7,127

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BOIRON